It's Better For Everyone: The Promise Of Liquid Biopsy As A Cancer Screening Tool

By Charles Chrisawn, Michael Edwards and Matthew Nowland

Cancer stands as the foremost global cause of mortality, responsible for nearly one out of every six deaths. Recent research indicates that approximately 15% of cancer-related fatalities could be prevented through early disease detection. However, the current landscape lacks comprehensive population-based screening programs, and even in cases where screening tests exist, adherence remains notably low.

Liquid biopsy tests, utilizing non-invasive sampling techniques to uncover information for cancer detection, hold substantial promise as an alternative to existing screening methods. They also offer the opportunity to create cancer detection tests for conditions where screening methods do not yet exist. As advancements in technology continue, the industry is expected to see the potential of detecting precancerous lesions or early tumors with a single small sample.

Read on as the authors of this post delve into the significance of early cancer detection and the present state of affairs, along with crucial considerations, when it comes to developing liquid biopsy solutions for cancer screening.